The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study.
Diabetes Res Clin Pract. 2017 Dec 16;136:159-167. doi: 10.1016/j.diabres.2017.12.008. [Epub ahead of print] Gamble JM, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Más información